UK Parliament / Open data

Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020

Debates on delegated legislation on Tuesday, 10 November 2020, in the House of Lords, led by Lord Grimstone of Boscobel. The answering member was Lord Bassam of Brighton.
Lords motion to consider. Agreed to on question.

About these Parliamentary proceedings

Reference

807 cc435-442GC 

Session

2019-21

Department

Department for International Trade

Procedure

Hybrid proceedings

Chamber / Committee

House of Lords Grand Committee

Related items

Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations
Wednesday, 2 September 2020
Statutory instruments
House of Lords
House of Commons
Secondary Legislation Scrutiny Committee twenty-sixth report.
Tuesday, 15 September 2020
Parliamentary committees
House of Lords
Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Tuesday, 17 November 2020
Parliamentary proceedings
House of Lords

Proceeding contributions

Lord Grimstone of Boscobel | 807 cc435-6GC (Link to this contribution)

My Lords, I hope that the Committee will be unanimous in support of these regulations and their o...

Lord Lansley | 807 cc436-8GC (Link to this contribution)

I thank noble Lords for the opportunity to participate in this brief debate on these regulations....


Show all contributions (5)
Lord Bassam of Brighton | 807 cc437-9GC (Link to this contribution)

My Lords, the Minister has said that these regulations will ensure that the tiered priced product...

Lord Grimstone of Boscobel | 807 cc439-441GC (Link to this contribution)

My Lords, I thank my noble friend Lord Lansley and the noble Lord, Lord Bassam of Brighton, for t...

Baroness Barker | 807 c442GC (Link to this contribution)

That completes the business before the Grand Committee this afternoon. I remind Members to saniti...

Subjects

Developing countries
EU law
Drugs
Labelling
Prices
Trade agreements
Logos
Medicines and Healthcare products Regulatory Agency
Brexit

Legislation

Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020

Link

View this Parliamentary proceeding on hansard.parliament.uk
Back to top